These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2665772)

  • 21. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrocytes are potent stimulators of anti-virus cytotoxic T cells.
    Balmelli C; Ruggli N; McCullough K; Summerfield A
    J Leukoc Biol; 2005 Jun; 77(6):923-33. PubMed ID: 15767291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
    Hackett CJ; Yewdell JW; Bennink JR; Wysocka M
    J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.
    De Bruijn ML; Nieland JD; Schumacher TN; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1992 Nov; 22(11):3013-20. PubMed ID: 1425925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Q7 alpha 3 domain alters T cell recognition of class I antigens.
    Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J
    J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominance of MHC class II-restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59.
    Heemskerk MH; Schoemaker HM; Spaan WJ; Boog CJ
    Immunology; 1995 Apr; 84(4):521-7. PubMed ID: 7790024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral antigen presentation and MHC assembly.
    Braciale TJ; Braciale VL
    Semin Immunol; 1992 Apr; 4(2):81-4. PubMed ID: 1617167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
    Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
    Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
    J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newly synthesized class II MHC chains are required for VSV G presentation to CTL clones.
    Reiss CS; Gapud CP; Keil W
    Cell Immunol; 1992 Jan; 139(1):229-38. PubMed ID: 1309489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
    Reimann J; Böhm W; Schirmbeck R
    Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells and antigen presentation in the regulation of cytotoxic T lymphocyte responses against viruses and transplantation antigens.
    Melief CJ; Boog CJ; Vasmel WL; Boes J; Voordouw AC; Kast WM
    Ann N Y Acad Sci; 1988; 532():280-91. PubMed ID: 2845847
    [No Abstract]   [Full Text] [Related]  

  • 39. Distinguishable pathways of viral antigen presentation to T lymphocytes.
    Morrison LA; Braciale VL; Braciale TJ
    Immunol Res; 1986; 5(4):294-304. PubMed ID: 3298467
    [No Abstract]   [Full Text] [Related]  

  • 40. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.
    Hosken NA; Bevan MJ
    J Exp Med; 1992 Mar; 175(3):719-29. PubMed ID: 1311017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.